Teladoc Health, Inc. (NYSE:TDOC) Receives Average Recommendation of “Hold” from Analysts

Teladoc Health, Inc. (NYSE:TDOC) has been given an average rating of “Hold” by the twenty-one brokerages that are currently covering the company, Marketbeat.com reports. Fourteen investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $12.24.

TDOC has been the topic of several recent analyst reports. Cantor Fitzgerald reissued an “overweight” rating and set a $10.00 target price on shares of Teladoc Health in a research note on Tuesday, August 20th. Royal Bank of Canada boosted their price objective on Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a research report on Wednesday, October 9th. Jefferies Financial Group lifted their price target on shares of Teladoc Health from $8.00 to $10.00 and gave the company a “hold” rating in a research note on Tuesday, September 17th. TD Cowen reduced their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Thursday, October 31st. Finally, Barclays lifted their target price on shares of Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st.

Insiders Place Their Bets

In other news, insider Carlos Nueno sold 2,389 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the sale, the insider now owns 2,890 shares in the company, valued at $34,477.70. This trade represents a 45.25 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.95% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in TDOC. Connor Clark & Lunn Investment Management Ltd. increased its position in shares of Teladoc Health by 15.5% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider’s stock worth $15,617,000 after purchasing an additional 228,004 shares during the last quarter. Clearline Capital LP increased its position in shares of Teladoc Health by 395.6% during the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock valued at $42,682,000 after acquiring an additional 3,483,665 shares during the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of Teladoc Health by 195.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 95,307 shares of the health services provider’s stock valued at $932,000 after acquiring an additional 63,028 shares during the period. Jennison Associates LLC acquired a new position in shares of Teladoc Health in the 3rd quarter worth approximately $1,544,000. Finally, Massachusetts Financial Services Co. MA boosted its position in shares of Teladoc Health by 477.1% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider’s stock worth $3,397,000 after purchasing an additional 305,961 shares during the period. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Stock Up 2.2 %

Teladoc Health stock opened at $10.42 on Friday. The business’s 50-day moving average price is $9.79 and its 200 day moving average price is $9.16. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The firm has a market cap of $1.79 billion, a price-to-earnings ratio of -1.81 and a beta of 0.97. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $22.54.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.51 million during the quarter, compared to analyst estimates of $630.50 million. As a group, sell-side analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.